Abstract: Acne is a chronic, immune-mediated, inflammatory disease with high prevalence among adolescents. By compromising face, thorax and back, with the risk of permanent scars, it has a negative impact on the quality of life. Effective, safe and early treatment is the key to remission, while decreasing the risk of physical and/or emotional sequelae. The Iberian--Latin American Group of Acne Studies joined professionals with expertise and developed a practical therapeutic algorithm, adapted to the reality of Latin American countries, Spain and Portugal. This article intends to disseminate it with an updated review on a rational, safe and effective acne treatment.
INTRODUCTION
Acne is one of the most common dermatological diseases seen by dermatologists in Latin America, Spain and Portugal, as well as in the rest of the world. It is a chronic inflammatory process that needs to be treated early and effectively to decrease the risk of physical and emotional sequelae. In this article, we present the result of the consensus among a group of dermatologists from Latin America, Spain and Portugal, based on the scientific evidence available in the literature and the experience of the members.
METHODS

A group of 33 dermatologists, members of the Iberian-Latin
American College of Dermatology -CILAD, and well-known acne specialists, created the Iberian-Latin American Group for the Study of Acne -GILEA. All the available scientific evidence was carefully chosen and several questions were developed in different face-toface meetings to initially determine the classification and gradation of the disease and subsequently the guidelines for the treatment of acne or therapeutic algorithm. Through these meetings and others, They may be used alone or in combination with benzoyl peroxide (PB) and topical antibiotics. Azelaic Acid (AA) Azelaic acid is a saturated dicarboxylic acid that normalizes follicular hyperkeratinization by a cytostatic effect on keratinocytes.
It decreases proliferation of P. acnes by inhibiting protein synthesis, and reduces inflammation by activating nuclear PPARγ receptors, inhibiting activation of NF-kB pathway and blocking the release of free radicals. It also has a bleaching action. AA is indicated for mild to moderate papular-pustular acne, particularly in patients with sensitive and darker skin, as well as in adult acne in women. AA is Category B for use in pregnancy. and not confirmed in population-based, case-control studies). 11-13 the recurrence of acne may occur within the first year after treatment.
Also, 29% of patients require more than one cycle, 25% two cycles and 3% three cycles. Light or LED -light emitting diode -blue or red exhibits photochemical, immunomodulatory and anti-inflammatory effects faster than drug treatment and can be associated in the early stages improving adherence to treatment. Photo-pneumatic therapy is a relatively new technology in the treatment of acne and appears to be effective in moderate cases combining photochemical effects with mechanical extrusion of comedones in addition to a light photothermal effect. Among the laser or light procedures, the most evidence is photodynamic therapy, which uses a photosensitizer, such as aminolevulinic acid, applied for 1 to 3 hours, during which it is absorbed by the sebocytes and later activated by a laser or light device, generating ROS that damage the sebaceous glands and reduce P. acnes. Although this treatment is promising, more controlled studies are needed to determine the ideal photosensitizer, incubation time, and light source. 17 
Dermocosmetics
In the mild and early forms of acne (comedonal, with hyperseborrhea), salicylic acid-based dermocosmetics, lipo-hydroxy-acids, retinol, glycolic acid (in low concentrations) and nicotinamide may be sufficient to control the disease. Moisturizers help to reduce adverse events of topical products and dryness due to oral isotretinoin, by improving the epidermal barrier that is essential to prevent and reduce inflammation. Sunscreens and nicotinamide prevent postinflammatory hyperpigmentation. Cleansing agents suitable for oily skin or sensitive skin, with ingredients that control sebaceous secretion, should be preferred. Camouflage with non-comedogenic makeup is useful for improving women's self-esteem. 4 Proper and honest use of these products benefit drug treatment, reduce adverse events, decrease the need for topical antibiotics and improve adherence/compliance to the therapeutic plan. 
